PyrAmes Inc.
PyrAmes is a digital health company focused on transforming healthcare delivery through advanced sensor measurement. The company is developing a proprietary platform for continuous, accurate, wireless, and non-invasive blood pressure monitoring for patients of all ages, from newborns to seniors. PyrAmes aims to make blood pressure monitoring easy, low-cost, unobtrusive, and painless, ultimately improving patient outcomes.
PyrAmes Inc.
21730 Stevens Creek Blvd, Suite 201A, Cupertino, CA 95014
PyrAmes Inc. is currently seeking investment
PyrAmes Inc. is seeking a series-b investment in the range of 5m-20m
What We Do
A non-invasive, continuous, wireless blood pressure monitoring device designed for neonatal patients, providing essential clinical information for critically ill infants.
An adult inpatient and emergency care platform for continuous non-invasive blood pressure monitoring.
A home monitoring system for diagnostics, treatment validation, and medical management, designed to provide continuous blood pressure monitoring for outpatient care.
Diagnostics
Application Area
Show LessFDA Regulated Medical Devices
Battlefield Resuscitation
Key People
Thomas Roxlo, PhD
Senior Data Scientist
Dave Richardson PhD, PE
Principal Engineer
Joe Zhou
Founder & Managing Director, Keytone Ventures
News & Updates
PyrAmes was selected as the best business pitch by a panel of expert judges at the American Heart Association’s annual Health Tech Competition during Scientific Sessions 2023.
PyrAmes CEO Xina Quan, Ph.D., was recognized as the sixth winner of TEAMFund's Annual Global Health Innovator Award, highlighting her contributions as a female founder in health technology.
PyrAmes announced it has received FDA 510(k) clearance for its Boppli® platform, enabling continuous and non-invasive blood pressure monitoring for critically-ill infants.